Benzinga's Top #PreMarket Losers

shares declined 15.03 percent to $20.41 in pre-market trading after the company reported weaker-than-expected results for its fiscal third quarter on Thursday.

fell 2.71 percent to $52.40 in pre-market trading. Bernstein downgraded ARM Holdings from Market Perform to Underperform.

shares fell 2.28 percent to $44.65 in pre-market trading. Alder BioPharmaceuticals priced its 4.494 million share offering at $44.50 per share.

shares dropped 1.70 percent to $31.45 in pre-market. Analysts at Jefferies maintain their Buy rating for Intel and lowered the target price from $48 to $45.

shares tumbled 1.07 percent to $14.74 in pre-market trading after rising 3.54 percent on Thursday.